Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS-Reference-Cited by-同舟云学术

Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS

Published:2007-01 Issue:5 Volume:8 Page:305-309
ISSN:1748-2968
Container-title:Amyotrophic Lateral Sclerosis
language:en
Short-container-title:Amyotrophic Lateral Sclerosis

Author:

Ajroud‐Driss Senda,Saeed Mohammad,Khan Humaira,Siddique Nailah,Hung W. Y.,Sufit Robert,Heller Scott,Armstrong Jennifer,Casey Pat,Siddique Teepu,Lukas Thomas J.

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/17482960701500650

Reference14 articles.

1. A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis

2. Dose-ranging study of riluzole in amyotrophic lateral sclerosis

3. Inter- and intraindividual variability of riluzole serum concentrations in patients with ALS

4. Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation and Optimization of a Microcavity Plate–Based Human Hepatocyte Spheroid Model for Predicting Clearance of Slowly Metabolized Drug Candidates;Drug Metabolism and Disposition;2024-05-22

2. Riluzole and its prodrugs for the treatment of Alzheimer’s disease;Pharmaceutical Patent Analyst;2023-03

3. Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study;Journal of Neurotrauma;2021-05-28

4. Natural Progression of Routine Laboratory Markers following Spinal Trauma: A Longitudinal, Multi-Cohort Study;2021-01-26

5. Discovery of Tirasemtiv, the First Direct Fast Skeletal Muscle Troponin Activator;ACS Medicinal Chemistry Letters;2018-02-13